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Abstract: 
 
Sixteen polyketides belonging to diverse structural classes, including monomeric/dimeric 
tetrahydroxanthones and resorcylic acid lactones, were isolated from an organic extract of a 
fungal culture Setophoma terrestris (MSX45109) by bioactivity‐directed fractionation as part of 
a search for anticancer leads from filamentous fungi. Of these, six were new: penicillixanthone B 
(5), blennolide H (6), 11‐deoxyblennolide D (7), blennolide I (9), blennolide J (10), and 
pyrenomycin (16). The known compounds were: secalonic acid A (1), secalonic acid E (2), 
secalonic acid G (3), penicillixanthone A (4), paecilin B (8), aigialomycin A (11), hypothemycin 
(12), dihydrohypothemycin (13), pyrenochaetic acid C (14), and nidulalin B (15). The structures 
were elucidated by a set of spectroscopic and spectrometric techniques: the absolute 
configurations of compounds 1–10 were determined by ECD spectroscopy combined with time‐
dependent density functional theory (TDDFT) calculations, whereas a modified Mosher's ester 
method was used for compound 16. The cytotoxic activities of compounds 1–15 against the 
MDA‐MB‐435 (melanoma) and SW‐620 (colon) cancer cell lines were evaluated. 
Compounds 1, 4, and 12were the most potent, with IC50 values ranging from 0.16 to 2.14 μM. 
When tested against a panel of bacteria and fungi, compounds 3 and 5 showed promising activity 
against the Gram‐positive bacterium Micrococcus luteus, with MIC values of 5 and 15 μg mL–1, 
respectively. 
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Article: 
 
Introduction 
 
Structurally diverse cytotoxic secondary metabolites have been isolated and identified from 
filamentous fungi of the Mycosynthetix library, representing over 55000 accessions, as part of 
ongoing bioactivity‐directed studies for discovery of anticancer drug leads.1 The organic extract 
of a solid‐phase culture of Setophoma terrestris (MSX45109), isolated from plant material 
collected in a mangrove habitat in 1989, showed potent cytotoxic activities against the SW‐620 
(colon) and MDA‐MB‐435 (melanoma) cancer cell lines (ca. 91 % and 100 % inhibition of cell 
growth, respectively, when tested at 20 μg mL–1). Of the hundreds of cultures that have been 
investigated as part of this project, S. terrestris was intriguing, due to the robust biosynthesis of 
16 polyketides (1–16) of distinct structural classes. Over a third of the isolated compounds were 
new, whereas structural revisions and augmentations to the literature were provided for several 
others. 
 
Compounds 1–10 (Figure 1, below) were identified as a series of monomeric/dimeric 
tetrahydroxanthones, an important class of mycotoxins produced by a variety of microorganisms 
displaying remarkable biological activities, including antitumor, antibacterial, and anti‐HIV.2 In 
this study, a series of new monomeric and homo‐/heterodimeric tetrahydroxanthones were 
identified, thereby expanding the diversity of this class of natural products and updating the 
literature on structural elucidation and absolute configuration considerations of structurally 
related compounds. These points are also critical for accurate and comprehensive dereplication 
studies of fungal metabolites, an area of growing prominence in the field.1a,3 Interestingly, a 
recent and comprehensive study reported a similar series of compounds, albeit with opposite 
absolute configurations.4 
 
Compounds 11–13 were characterized as a series of structurally related resorcylic acid lactones 
(RALs), a family of benzannulated macrolides produced by a variety of fungi exhibiting a wide 
range of biological activities, including antitumor, antifungal, antibiotic, and antiviral.5 
Compounds 14 and 16, biogenetically related to RALs, were also isolated and identified. 
 
The absolute configurations of compounds 1–10 were determined with the aid of time‐dependent 
density functional theory (TDDFT) calculations of ECD spectra, whereas for 16 a modified 
Mosher's ester method was used. The dimeric tetrahydroxanthone derivatives 1and 4 and the 
RAL 12 all showed potent inhibition of MDA‐MB‐435 and SW‐620 cancer cell lines. On the 
other hand, compounds 3 and 5 showed promising activity against the Gram‐positive bacterium 
Micrococcus luteus. 
 
Results and Discussion 
 
The organic extract of a large‐scale solid‐substrate fungal culture of S. terrestris (MSX45109) 
showed potent cytotoxic activity against the SW‐620 and MDA‐MB‐435 cancer cell lines, and so 
it was fractionated by silica gel flash chromatography to yield five fractions. The third fraction, 
which eluted with 10 % MeOH/CHCl3, showed potent cytotoxic activity against the two cancer 
cell lines, and as such, it was purified by reversed‐phase preparative and semipreparative HPLC 
to yield polyketides 1–16. The purities of the isolated compounds were verified by UPLC 
(Figure S1 in the Supporting Information). 
 
 
Figure 1. Compounds 1–16 from S. terrestris (MSX45109). 
 
Monomeric/Dimeric Tetrahydroxanthones 
 
Compounds 1–10 were identified as a series of monomeric (6–8), homodimeric (1–5), and 
heterodimeric (9 and 10) tetrahydroxanthones by comparison of HRMS, NMR, and ECD data 
with each other and with structurally related compounds (Figure 1). Stereoisomeric compounds 
1 (35.1 mg), 2 (51.3 mg), and 3 (9.5 mg) were all obtained as yellow powders and had molecular 
formulae of C32H30O14 as determined by HRMS (ESI). The 1H and 13C NMR spectra of 
compounds 1 and 2 showed the presence of only 15 H and 16 C atoms, indicating that these 
compounds were homodimers, whereas 3 was clearly a heterodimer (Figures S2–S4 in the 
Supporting Information). A search of the “Dictionary of Natural Products”6 for the molecular 
formula and a UV range of 325–345 nm resulted in twelve hits, five of which were excluded on 
the basis of NMR spectroscopic data. The remaining seven hits were the secalonic acids A–G, 
each containing a 2,2′‐linkage. The fact that compounds 1 and 2 were homodimeric cut down the 
number of possibilities for compounds 1 and 2 to secalonic acids A, B, D, or E, whereas the 
heterodimeric nature of 3 suggested secalonic acid C, F, or G. Key differences between 
compounds 1 and 2 were the chemical shift values and splitting patterns of 5‐H, 6‐H, and H2‐7. 
A proton doublet of doublets corresponding to 5‐H/5′‐H (δH = 3.92 ppm, dd, J = 11.2, 0.5 Hz) 
in 1 was downfield‐shifted in 2 (δH = 4.11 ppm, d, J = 1.2 Hz). These J values implied a 
pseudodiaxial trans orientation of 5‐H/6‐H in 1 and a pseudoaxial/pseudoequatorial cis 
orientation in 2 (Figures S2 and S3, Table S1 in the Supporting Information). On the other hand, 
the 1H NMR spectrum of 3 showed similarity with the 1H NMR spectra of both 1 and 2, 
revealing two sets of protons corresponding to asymmetric monomers (Figure S4, Table S1 in 
the Supporting Information). The 2,2′‐linkage in each of 1–3 was confirmed by diagnostic 
HMBC correlations of 3‐H and 3′‐H with C‐2′ and C‐2, respectively. 
 
 
Figure 2. Comparison of the experimentally measured ECD spectra of secalonic acids A (1), E 
(2), and G (3) [0.03 mM CHCl3, cell length 2 cm]. 
 
The absolute configurations of the 2,2′‐secalonic acids have been determined by ECD 
spectroscopy.7 The Cotton effect around 330 nm corresponds to the n–π* electronic transition, 
and it has been correlated with the configurations of C‐10a and C‐10a′.7a,8 Negative Cotton 
effects at 332 nm in the ECD spectra of compounds 1, 2, and 3 (Δϵ = –38.8, –24.6, and –31.2, 
respectively), indicated the S configuration at both C‐10a and C‐10a′ (Figure 2). This allowed the 
assignment of the R configuration at C‐6 and C‐6′ on the basis of the trans orientation of the C‐
6/6′ and C‐10a/10a′ substituents deduced from the biosynthetic route for the formation of 
stereoisomeric tetrahydroxanthone precursors of secalonic acids, with no exception so far in the 
literature.9 Combining all the data together suggested the absolute configurations as 
(5S,6R,10aS,5′S,6′R,10a′S), (5R,6R,10aS,5′R,6′R,10a′S), and (5R,6R,10aS,5′S,6′R,10a′S) for 
compounds 1–3, respectively. Consequently, compounds 1–3 were identified as secalonic acid 
A,10 secalonic acid E,11 and secalonic acid G,12 respectively, in accordance with published data 
(Table S2 in the Supporting Information). Most literature pertaining to these compounds dates 
back to the 1960s and 1970s, and so the 1H and 13C NMR spectroscopic data for 1–3 are 
provided in Figures S2–S4 and Table S1 in the Supporting Information. 
 
 
Figure 3. Experimentally measured and calculated ECD spectra for penicillixanthone A (4, 0.05 
mM, CHCl3, cell length 2 cm). 
 
Compound 4 (5.4 mg) was obtained as a yellow powder. Its chemical formula was determined to 
be C32H30O14 by HRMS (ESI) and analysis of 1H, 13C, and edited‐HSQC NMR spectroscopic 
data (Figure S5 and Table S3 in the Supporting Information). These data suggested an 
asymmetric secalonic acid analogue with structural similarity to 1. However, a key difference 
between 4 and 1 was the linkage of the monomeric units, this being 2,2′ in 1 versus 2,4′ in 4, thus 
making 4 asymmetric, as evidenced by diagnostic HMBC correlations of 3‐H and 3′‐H with C‐4′ 
and C‐4, respectively (Figure S6 in the Supporting Information). The two monomeric moieties 
in 4 were assigned the same configuration as in 1, as evidenced by a negative Cotton effect at 
331 nm in the ECD spectrum of 4 (Δϵ = –24.8), and negative values of optical rotation for both 1 
and 4 (Figure 2, Figure S7 and Table S2 in the Supporting Information). The absolute 
configuration of 4 was established as (5S,6R,10aS,5′S,6′R,10a′S) by comparing experimentally 
measured and calculated ECD spectra predicted by the time‐dependent density functional 
theory/electronic circular dichroism (TDDFT‐ECD) approach (Figure 3).13 Briefly, conformation 
analysis of 3D models of compound (5S,6R,10aS,5′S,6′R,10a′S)‐4 and its hypothetical 
enantiomer (5R,6S,10aR,5′R,6′S,10a′R)‐4a gave 12 and 11 conformers, respectively, within a 2 
kcal mol–1 energy window from the global minimum. All conformers were geometrically 
optimized at the B3LYP/DGDZVP level.14 Relative free energies (ΔG°) as well as the 
Boltzmann distributions for the most relevant optimized conformers are given in the Supporting 
Information (Figure S8). The Boltzmann‐averaged ECD spectra of re‐optimized conformers 
of 4 based on TDDFT showed an excellent fit with the experimentally measured data, with a 
negative Cotton effect around 320 nm (n–π* transition), whereas the 4a enantiomer showed a 
positive Cotton effect at the same wavelength (Figure 3). The NMR (Figure S5 and Table S3 in 
the Supporting Information) and optical rotation data (Table S2 in the Supporting Information) 
were in agreement with those reported for penicillixanthone A, though the absolute configuration 
was not determined.15 Interestingly, compound 4 was reported by Kurobane et al.16 as a 
chemically rearranged analogue of 1 obtained by dissolving 1 in polar organic solvents, such as 
pyridine, acetone, or acetonitrile, either at room temperature or above for hours to days, 
depending on the solvent used. This suggests that 4 might have been an artefact of the 
purification scheme. 
 
 
Figure 4. Key COSY, HMBC, and NOESY correlations of 5–10 and 16. Gaussian 09 was used 
for ground‐state mechanics optimization, based on the NOESY correlations, to generate the 
structures shown on the right. 
 
Compound 5 (2.1 mg), obtained as a yellow powder, had a chemical formula of C32H30O14 as 
determined by HRMS (ESI) and analysis of 1H, 13C, and edited‐HSQC NMR spectroscopic data 
(Figure S9 in the Supporting Information), corresponding to an index of hydrogen deficiency of 
18. The NMR spectroscopic data suggested an asymmetric secalonic acid analogue with 
structural similarity to 2 (Figure 4, Figure S9 in the Supporting Information, Table 1). However, 
as was also observed in 1 versus 4, the 2,2′‐linkage in 2 was supplanted by a 2,4′‐linkage in 5, as 
evidenced by diagnostic HMBC correlations of 3‐H and 3′‐H with C‐4′ and C‐4, respectively 
(Figure 4). Two singlets, corresponding to 5‐H/5′‐H (δH = 4.14/3.99 ppm) in 5, implied a 
pseudoaxial/pseudoequatorial cis orientation of 5‐H/6‐H and 5′‐H/6′‐H, similar to that in 2; this 
was further supported by NOESY correlations between 5‐H/6‐H and 5′‐H/6′‐H (Figure 4). The 
two monomeric moieties in 5 were assigned the same configuration as in 2, as evidenced by a 
negative Cotton effect at 332 nm in the ECD spectrum of 5 (Δϵ = –18.9, Figure S7 in the 
Supporting Information) and negative values of optical rotation for both compounds (Table S2 in 
the Supporting Information). The absolute configuration of 5 was established as 
(5R,6R,10aS,5′R,6′R,10a′S) by comparing experimentally measured ECD spectra and those 
calculated by TDDFT by use of the same protocol as described for compound 4 (Figure 5 and 
Figure S10 in the Supporting Information).13a–13d These data suggested the structure of 5, which 
was ascribed the trivial name penicillixanthone B. As noted for 4,10 compound 5 was potentially 
an artefact produced by rearrangement of 2 in polar organic solvents. 
 
Table 1. NMR spectroscopic data for 5 (500 MHz for 1H, 125 MHz for 13C; chemical shifts in δ, 
coupling constants in Hz, CDCl3). 
Position δC δH mult. (J in Hz) Position δC δH mult. (J in Hz) 
1 159.4 
 
1′ 161.9 
 
2 119.4 
 
2′ 110.8 6.60, d (8.6) 
3 139.6 7.47, d (8.6) 3′ 140.1 7.33, d (8.6) 
4 107.9 6.58, d (8.6) 4′ 115.9 
 
4a 157.2 
 
4a′ 154.5 
 
5 71.5 4.14, s 5′ 70.9 3.99, s 
6 28.6 2.12, m 6′ 28.5 2.12, m 
7 32.7 2.38, m 7′ 32.6 2.38, m   
2.49, m 
  
2.49, m 
8 180.2 
 
8′ 179.4 
 
8a 99.9 
 
8a′ 99.7 
 
9 187.6 
 
9′ 187.9 
 
9a 107.0 
 
9a′ 106.9 
 
10a 84.9 
 
10a′ 84.4 
 
11 17.6 1.17, dd (6.9, 0.6) 11′ 17.6 1.13, dd (6.9, 0.6) 
12 171.4 
 
12′ 170.9 
 
13 53.7 3.75, s 13′ 53.4 3.64, s 
1‐OH 
 
11.91, s 1′‐OH 
 
11.56, s 
5‐OH 
 
2.55, br. s 5′‐OH 
 
2.77, br. s 
 
 
Figure 5. Experimentally measured and calculated ECD spectra for penicillixanthone B (5, 0.06 
mM, CHCl3, cell length 2 cm). 
 
Table 2. NMR spectroscopic data for 6 (500 MHz for 1H, 175 MHz for 13C; chemical shifts in δ, 
coupling constants in Hz, CDCl3). 
Position δC δH mult. (J in Hz) 
1 163.0 
 
2 110.5 6.54, dd (8.6, 0.6) 
3 138.5 7.39, dd (8.6, 8.0) 
4 107.7 6.56, dd (8.0, 0.6) 
4a 159.5 
 
5 77.5 3.92, dd (11.5, 2.9) 
6 30.0 2.36, m 
7 33.8 2.16, ddd (20.6, 10.3, 2.9)   
2.72, dt (20.6, 5.2) 
8 141.9 7.23, dd (5.2, 2.9) 
8a 129.9 
 
9 184.7 
 
9a 107.7 
 
10a 85.8 
 
11 17.7 1.15, d (6.3) 
12 169.1 
 
13 53.3 3.69, s 
1‐OH 
 
12.00, s 
5‐OH 
 
2.74, s 
 
Compound 6 (0.8 mg) was obtained as a yellow gum. Its molecular formula was deduced to be 
C16H16O6 by HRMS (ESI) and analysis of 1H, 13C and edited‐HSQC NMR spectroscopic data 
(Figure S11 in the Supporting Information), indicating an index of hydrogen deficiency of 9. 
Inspection of the HRMS and NMR spectroscopic data suggested that 6 was a tetrahydroxanthone 
derivative with structural similarity to the monomeric unit of 1. However, key differences were 
the replacement of the C‐2 quaternary carbon in 1 (δC = 118.3 ppm) by an aromatic methine 
system in 6 (δH/δC = 6.54/110.5 ppm), and the replacement of the hydrogen‐bonded phenolic 
proton in 1 (δH = 13.78 ppm) by an olefinic proton in 6 (δH = 7.23 ppm, Table 2, Figure S11 in 
the Supporting Information). COSY data identified two spin systems as 2‐H/3‐H/4‐H and 5‐H/6‐
H/H2‐7/8‐H (Figure 4). Further examination of the NMR spectra, including HMBC data (Figure 
4), yielded a planar structure of 6, which was ascribed the trivial name blennolide H. The relative 
configuration of 6 was found to be (5S,6R,10aS), the same as that of the monomeric units of 1, 
deduced from NOESY correlations and coupling constants for both compounds (Figure 4). 
However, the ECD calculations suggested the opposite (5R,6S,10aR) configuration (Figure S12 
in the Supporting Information). Because this finding was inconsistent with biosynthetic 
considerations, the calculations were repeated, to yield identical results. As such, we regard the 
absolute configuration of 6 as tentative. 
 
 
Figure 6. Experimentally measured ECD spectra of 11‐deoxyblennolide D (7, 0.16 mM) and 
paecilin B (8, 0.56 mM, CHCl3, cell length 2 cm). 
 
Diastereoisomers 7 (5.4 mg) and 8 (1.0 mg) were obtained as colorless oils and both had 
molecular formulae of C16H16O7, as determined by HRMS (ESI) and analysis of 1H, 13C, and 
edited‐HSQC NMR spectroscopic data (Figures S13 and S14 in the Supporting Information), 
corresponding to an index of hydrogen deficiency of 9. Compounds 7 and 8 showed similar 1H 
and 13C NMR spectra (Table 3) with small differences in four chemical shift values. 
Interestingly, compounds 7 and 8 displayed opposite signs for optical rotation data: whereas 
compound 7 was levorotatory (–26.14°), compound 8 was dextrorotary (+42.05°, Table S2 in the 
Supporting Information). Moreover, the ECD spectra of 7 and 8 were mirror images (Figure 6). 
Analysis of the HRMS and NMR spectroscopic data indicated that 7 and 8 were monomers and 
structurally related to the monomeric units of compounds 1–5. In comparison with the 
chromanone moiety in compounds 1–5, rings A and B were preserved in 7 and 8, as evidenced 
by comparable 13C NMR spectroscopic data and the hydrogen‐bonded phenolic proton (δH = 
11.43 ppm), except for a quaternary aromatic carbon that was replaced by an aromatic methine 
system in 7 and 8. In contrast, however, ring C had experienced significant changes, as 
evidenced by 1D‐ and 2D‐NMR spectroscopic data. For example, the 13C NMR spectra 
displayed signals characteristic of ester functionalities (δC = 175.3 and 175.7 ppm for 7 and 8, 
respectively; Table 3). Thus, ring C was established as a γ‐lactone moiety, as evidenced by the 
COSY spin system of 9‐H/10‐H/(H3‐13)/11‐H and HMBC correlations from H3‐13 to C‐11 and 
C‐9, from 9‐H to C‐12, and from 11‐H to C‐9 (Figure 4). On the other hand, HMBC correlations 
from H2‐3 to C‐9 and C‐14 and from 9‐H to C‐14 indicated a 2,9‐linkage between the 
chromanone and the γ‐lactone moieties, establishing the planar structures of 7 and 8 (Figure 4). 
The relative configuration of ring C in compounds 7 and 8 was similar, on the basis of NOESY 
correlations between H3‐13 and 9‐H and coupling constant values of 4.0 and 3.4 ppm for 9‐H in 
compounds 7 and 8, respectively, implying a pseudodiaxial trans orientation of 9‐H/10‐H 
(Figure 4, Table 3). The spatial arrangements of 7and 8 were different, as observed from NOESY 
data, particularly between 10‐H to 11α‐H and 3α‐H, as well as 9‐H to H2‐3 in 7 and from 9‐H to 
3α‐H in 8 (Figure 4). Putting these data together, and taking into consideration the fact that 
compounds 7 and 8 could not be enantiomers, because they had been separated by non‐
enantioselective methods, compounds 7 and 8 could either be epimers at C‐2 (2R9S10S or 
2S9S10S) or have the same configuration at C‐2 but the opposite configuration of ring C. The 
absolute configurations of 7 and 8 were established by comparing the experimentally measured 
ECD data with those obtained through molecular modeling calculations (Figures S15 and S16 in 
the Supporting Information). The excellent fit between the observed and calculated ECD plots 
(Figure 7) established the absolute configuration of 7 as (2S,9S,10S) and that of 8 as (2R,9S,10S), 
supporting epimerization at C‐2. The NMR (Table S4 in the Supporting Information) and optical 
rotation data for 8 (Table S2 in the Supporting Information) indicated similarity with paecilin B 
(isolated from the mangrove endophytic fungus Paecilomyces sp.), the planar structure of which 
was published in 2007.17 However, significant differences in the 1H and 13C NMR spectroscopic 
data for compound 8 and for paecilin B were observed (Table S4 in the Supporting Information). 
Recently, paecilin B was reported as a monomer and as a subunit of a dimer from the seagrass‐
derived fungus Bipolaris sp.18 Our data were in agreement with this study, including the absolute 
configuration. With respect to compound 7, two structurally related compounds, blennolide D 
and blennolide E, in which C‐11 is hydroxylated, were reported previously from Blennoria sp.4 
Hence, the trivial name 11‐deoxyblennolide D was ascribed to 7. The planar structures of 
compounds 7 and 8 were reported previously, on the basis of their synthesis, but without 
reporting of NMR spectroscopic data.19 
 
Table 3. NMR spectroscopic data for 7 and 8 (500 MHz for 1H, 125 MHz for 13C; chemical 
shifts in δ, coupling constants in Hz, CDCl3). 
Position 7 8  
δC δH mult. (J in Hz) δC δH mult. (J in Hz) 
2 84.3 
 
84.3 
 
3 39.8 3.04, dd (17.2, 0.6) 40.7 3.07, d (17.2)   
3.17, d (17.2) 
 
3.48, d (17.2) 
4 194.1 
 
194.9 
 
4a 107.7 
 
107.5 
 
5 162.0 
 
161.9 
 
6 110.7 6.55, dd (8.6, 0.6) 110.6 6.54, dd (8.6, 0.6) 
7 139.2 7.42, t (8.6) 139.0 7.40, t (8.6) 
8 107.7 6.54, dd (8.6, 0.6) 107.5 6.49, dd (8.6, 0.6) 
8a 159.2 
 
159.3 
 
9 87.6 4.43, dd (4.0, 0.6) 86.5 4.36, dd (3.4, 0.6) 
10 30.1 2.83, m 29.7 2.85, m 
11 36.2 2.21, dd (17.8, 4.6) 36.4 2.21, dd (17.8, 4.6)   
2.89, dd (17.8, 9.2) 
 
3.01, dd (17.8, 9.2) 
12 175.3 
 
175.7 
 
13 20.9 1.28, d (6.9) 20.7 1.18, d (6.9) 
14 168.9 
 
169.2 
 
15 53.8 3.72, s 53.7 3.74, s 
5‐OH 
 
11.43, s 
 
11.45, s 
 
 
Figure 7. Experimentally measured and calculated ECD spectra for 11‐deoxyblennolide D (7, 
0.16 mM) and paecilin B (8, 0.56 mM, CHCl3, cell length 2 cm). 
 
Compound 9 (1.1 mg) was isolated as a yellow gum with a molecular formula of C32H30O14as 
deduced from HRMS (ESI) and 1H, 13C, and edited‐HSQC NMR spectroscopic data (Figure S17 
in the Supporting Information), indicating an index of hydrogen deficiency of 18. Analysis of the 
NMR spectroscopic data, including HMBC and NOESY spectra, suggested that 9 was a 
heterodimer, with one monomeric moiety similar to a monomeric unit of 2 and the other similar 
to 7 (Table 4, Figure 4). A key difference between a monomeric moiety in 9 that was related to 7 
was the replacement of the C‐6 aromatic methine (δH/δC = 6.55/110.7 ppm) in 7 by a quaternary 
carbon in 9 (δC‐6′ = 118.1 ppm). A 2,6′‐linkage in 9 was evident from diagnostic HMBC 
correlations of 3‐H to C‐6′ and 7′‐H to C‐2, establishing the planar structure of 9 (Figure 4). The 
absolute configuration was deduced on the basis of the monomeric constituents. The secalonic 
acid moiety was assigned the same configuration as in 2, as evidenced from similar NOESY 
correlations and coupling constant values of 5‐H and preservation of the configuration at C‐10a 
through the series. In addition, the moiety similar to 7 was assigned the same configuration as 7 
on the basis of consistencies in the 1H, 13C, and NOESY NMR spectroscopic data (Table 3 and 
Table 4, Figure 4). Hence, the absolute structure of 9 was assigned as (5R,6R,10aS,2′S,9′S,10′S) 
and confirmed by ECD calculations (Figure 8, Figures S18 and S19 in the Supporting 
Information). The NMR spectroscopic data for 9 were found to be in agreement with those for 
blennolide G, which was reported previously from Blennoria sp.4 However, compound 9 and 
blennolide G showed opposite ECD and optical rotation data, and opposite absolute 
configuration at four chiral centers, thus indicating that 9 was a diastereoisomer of blennolide G 
(Table S2 in the Supporting Information, Figure 9). The trivial name blennolide I was ascribed 
to 9. 
 
 
 
 
 
 
 
Table 4. NMR spectroscopic data for 9 and 10 (700 MHz for 1H, 175 MHz for 13C; chemical 
shifts in δ, coupling constants in Hz, CDCl3). 
Position 9 10  
δC δH mult. (J in Hz) δC δH mult. (J in Hz) 
1 159.4 
 
159.3 
 
2 118.3 
 
117.8 
 
3 139.6 7.42, d (8.3) 140.1 7.45, d (8.5) 
4 107.5 6.57, d (8.3) 107.5 6.62, d (8.5) 
4a 157.2 
 
158.4 
 
5 71.3 4.12, s 78.0 3.93, dd (11.2, 2.7) 
6 28.5 2.11, m 29.2 2.41, m 
7 32.6 2.40, dd (18.9, 6.1) 36.2 2.32, dd (19.4, 10.6)   
2.52, dd (18.9, 11.2) 
 
2.73, dd (19.4, 6.5) 
8 179.9 
 
177.6 
 
8a 99.9 
 
101.5 
 
9 187.5 
 
187.1 
 
9a 107.0 
 
106.9 
 
10a 84.8 
 
84.8 
 
11 17.5 1.17, d, (7.1) 18.0 1.17, d, (6.5) 
12 171.2 
 
170.2 
 
13 53.5 3.71, s 53.3 3.71, s 
1‐OH 
 
11.85, s 
 
11.72, s 
5‐OH 
 
2.52, br. s 
 
2.77, d (2.7) 
8‐OH 
 
13.95, s 
 
13.76, s 
2′ 84.2 
 
84.2 
 
3′ 39.7 3.05, d (17.0) 39.7 3.05, d (17.0)   
3.21, d (17.0) 
 
3.21, d (17.0) 
4′ 194.0 
 
194.0 
 
4a′ 107.6 
 
107.6 
 
5′ 159.2 
 
159.2 
 
6′ 118.1 
 
118.1 
 
7′ 141.3 7.52, d (8.3) 141.3 7.51, d (8.5) 
8′ 107.3 6.61, d (8.3) 107.3 6.62, d (8.5) 
8a′ 158.6 
 
158.6 
 
9′ 87.5 4.45, d (3.8) 87.5 4.46, d (4.1) 
10′ 30.0 2.84, m 30.0 2.84, m 
11′ 36.0 2.91, dd (18.0, 9.3) 36.0 2.92, dd (17.9, 9.4)   
2.23, dd (18.0, 4.8) 
 
2.22, dd (17.9, 4.6) 
12′ 175.1 
 
175.1 
 
13′ 20.9 1.28, d (7.1) 20.9 1.28, d (6.8) 
14′ 168.8 
 
168.8 
 
15′ 53.7 3.76, s 53.7 3.75, s 
5′‐OH 
 
11.88, s 
 
11.89, s 
 
 
Figure 8. Experimentally measured and calculated ECD spectra for blennolide I (9, 0.06 mM, 
CHCl3, cell length 2 cm). 
 
 
Figure 9. Experimentally measured and calculated ECD spectra for blennolide J (10, 0.17 mM, 
CHCl3, cell length 2 cm). 
 
Compound 10 (0.6 mg), isolated as a yellow gum, had a molecular formula of C32H30O14 as 
deduced from HRMS (ESI) and 1H, 13C, and edited‐HSQC NMR spectroscopic data (Figure S20 
in the Supporting Information), indicating an index of hydrogen deficiency of 18. Analysis of the 
NMR spectroscopic data indicated that 10 was an asymmetric heterodimer with structural 
similarity to 9. Key differences between 9 and 10 were chemical shift values and splitting 
patterns of 5‐H, 6‐H, and H2‐7 (Table 4, Figures S17 and S20 in the Supporting Information). A 
proton singlet in 9 (δH = 4.12 ppm), corresponding to 5‐H, was replaced by a doublet of doublets 
(δH = 3.93 ppm, dd, J = 11.2, 2.7 Hz) in 10, suggesting a pseudodiaxial trans orientation of 5‐
H/6‐H in 10. These data indicated that the secalonic acid moiety in 10was similar to the 
monomeric units of 1, whereas the 11‐deoxyblennolide D moiety was preserved, as in 9. A 2,6′‐
linkage in 10, also similar to 9, was confirmed by diagnostic HMBC correlations of 3‐H with C‐
6′ and 7′‐H with C‐2, establishing the planar structure of 10 (Figure 4). As in the case of 9, the 
absolute configuration of 10 was deduced on the basis of the monomeric constituents and ECD 
calculations to be (5S,6R,10aS,2′S,9′S,10′S) (Figure 9, Figures S18 and S21 in the Supporting 
Information). The trivial name blennolide J was ascribed to compound 10. 
 
In addition to compounds 1–10, the biogenetically related benzophenone nidulalin B (15, 1.7 
mg) was isolated and identified by comparison of its spectroscopic and spectrometric data with 
those reported in the literature (Figure S26 in the Supporting Information).20 
 
Resorcylic Acid Lactones 
 
Compounds 11–13 were identified as the resorcylic acid lactones aigialomycin A (4.2 mg),21 
hypothemycin (19.6 mg),22 and dihydrohypothemycin (3.7 mg),21 respectively (Figures S22–S24 
in the Supporting Information), whereas compound 14 was the biogenetically related 
pyrenochaetic acid C (2.7 mg, Figure S25 in the Supporting Information).23 In all cases, the 
spectroscopic and spectrometric data were in agreement with those reported in the literature. 
 
Compound 16 (0.8 mg) was isolated as a colorless oil with a molecular formula of C12H14O5as 
revealed by HRMS (ESI) and 1H, 13C, and edited‐HSQC NMR spectroscopic data (Figure S27 in 
the Supporting Information), indicating an index of hydrogen deficiency of six. UV absorption 
maxima of 301, 270, and 233 nm were indicative of an aromatic carbonyl compound.24 
Inspection of the NMR spectroscopic data showed signals characteristic of six aromatic carbons, 
two of which were oxygenated, two doublet aromatic protons with coupling constant values of 
2.3 Hz, and two phenolic protons (Table 5, Figure S27 in the Supporting Information). These 
data suggested a 1,2,3,5‐tetrasubstituted benzene ring with two aromatic protons meta to each 
other (Figure S27 in the Supporting Information, Table 5). Benzene ring substituents were 
confirmed by HMBC correlations (Figure 4). COSY data identified a 1,2,3‐trisubstituted pentane 
moiety (H2‐4/3‐H/11‐H/12‐H/13‐H) with C‐3 and C‐11 being oxygenated and C‐4 attached to the 
benzene ring (Figure 4). HMBC correlations from H2‐4 to C‐6 and C‐10 confirmed C‐5 as the 
attachment point of the aliphatic side chain with the aromatic ring. Chemical shift values 
(δH/δC = 4.43/81.1 ppm) for 3‐H/C‐3 indicated esterification of C‐3 to form a six‐membered ring 
with the ester carbonyl group (δC = 170.2 ppm) that was attached to the benzene ring at C‐2. 
Further examination of the NMR spectroscopic data yielded the planar dihydroisocoumarin 
structure of 16, which was ascribed the trivial name pyrenomycin. The absolute configuration 
of 16 was assigned by a modified Mosher's ester method,25 establishing the configuration as 
3R and 11S (Figure 10). Similar dihydroisocoumarin compounds have been isolated previously 
from marine sponges, plants, fungi, and insects; they include hiburipyranone,26 3‐(2‐
hydroxypropyl)‐8‐hydroxy‐3,4‐dihydroisocoumarin,27 and (3S,1′R)‐3‐(1‐hydroxyethyl)‐6,8‐
dihydroxy‐7‐methyl‐3,4‐dihydroisocoumarin.28 
 
 
Figure 10. ΔδH values [Δδ (in ppm) = δS – δR] obtained for (S)‐ and (R)‐MTPA esters 
(16a and 16b, respectively) of pyrenomycin (16) in [D5]pyridine. 
 
Table 5. NMR spectroscopic data for 16 (700 MHz for 1H, 175 MHz for 13C; chemical shifts 
in δ, coupling constants in Hz, CD3OD). 
Position δC δH mult. (J in Hz) 
1 170.2 
 
3 81.1 4.43, dt (12.7, 3.3) 
4 29.0 2.75, dd (16.4, 3.3)   
3.11, dd (16.4, 12.7) 
5 142.2 
 
6 107.2 6.21, br. d (2.3) 
7 164.2 
 
8 100.9 6.15, d (2.3) 
9 168.8 
 
10 99.6 
 
11 73.1 3.58, dt (8.6, 3.3) 
12 25.1 1.67, m 
13 9.2 1.03, t (7.5) 
9‐OH 
 
8.55, s 
11‐OH 
 
1.28, br. s 
7‐OH 
 
4.57, br. s 
 
Cytotoxicities and Antimicrobial Evaluations of Isolated Compounds 
 
Compounds 1–15 were tested for cytotoxicity against the MDA‐MB‐435 and SW‐620 cancer cell 
lines. Of the tetrahydroxanthone derivatives, 1 and 4 were the most potent, with IC50values less 
than 0.50 μM in both cell lines (Table 6). From the cytotoxicity data for related analogues, the 
importance of the configuration of C‐5/C‐5′ became evident (Table 6). Compounds 1 and 4, each 
with (5S,5′S) configuration, and with a 2,2′‐ and a 2,4′‐linkage for 1and 4, respectively, were the 
most potent. A (5S,5′R) configuration, as in 3, resulted in a compound approximately 20 times 
less active than 1, whereas a (5R,5′R) configuration rendered 2 inactive; both had a 2,2′‐linkage 
of the monomeric units. For those with a 2,4′‐linkage, compound 5, with (5R,5′R) configuration, 
was approximately 30 times less active than 4. Heterodimeric 10, composed of the monomeric 
units of 1 and compound 7, was approximately 25 times less active than 1. Compound 9, 
composed of the monomeric units of 2 and compound 7, was inactive. The difference in the 
potencies of 10 and 9 further supported the importance of the (5S,5′S) configuration, and all three 
monomeric compounds (6–8) were inactive. Consistent with the cytotoxicity data obtained in 
this study, 1 and its chemically rearranged 2,4′‐dimer 4 were reported to have equipotent activity 
against cultured mouse leukemia L1210 cells.2d Moreover, 1 has been reported to have a 
protecting effect for the dopaminergic neurons from cell death induced by 1‐methyl‐4‐
phenylpyridinium (MPP+) salts29 and to attenuate colchicine‐induced apoptosis of the cortical 
neurons.30 
 
In agreement with the literature,5 cytotoxicity data for the structurally related RALs 11–13 
indicated the importance of the (Z)‐enone for activity, as in hypothemycin (12, IC50 value of 0.58 
μM, MDA‐MB‐435). Alternatively, aigialomycin A (11), with an (E)‐enone, and 
dihydrohypothemycin (13), with a reduced enone, were both inactive (IC50 value > 10 μM). 
RALs containing (Z)‐enone systems have been reported as potent inhibitors of several ATPases 
and kinases, including TAK1.31 
 
Table 6. Cytotoxicities of compounds 1–15 against two human tumor cell lines. 
Compound[a] IC50 values in μM[b]  
MDA‐MB‐435[c] SW‐620[c] 
1 0.16 0.41 
2 n.a. 19.12 
3 3.27 3.67 
4 0.18 0.21 
5 5.20 5.55 
10 4.06 6.14 
12 0.58 2.14 
[a] Compounds 6–9, 11, and 13–15 were inactive, with IC50 values > 20 μM. 
[b] IC50 values were determined as the concentrations required to inhibit growth to 50 % of control with 72 h 
incubation. 
[c] Positive control was vinblastine, tested at concentrations of 1 nM in MDA‐MB‐435 cells and 10 nM in 
SW620 cells, which had 23 % and 76 % viable cells, respectively. 
 
The antimicrobial activities of the isolated compounds 1–15 were evaluated against a panel of 
bacteria and fungi (Table 7 and Figure S5 in the Supporting Information). Compounds 3 and 5 
showed promising activity against the Gram‐positive bacterium Micrococcus luteus, with MIC 
values of 5 and 15 μg mL–1, respectively. Secalonic acid A (1) was reported to have activity 
against Bacillus subtilis and Piriculaia oryzae2b and a phlogistic activity,32 whereas 
penicillixanthone A (4) was reported to have medium antibacterial activity against M. luteus, 
Pseudoalteromonas nigrifaciens, and B. subtilis.33 Interestingly, compounds 3 and 5, which were 
both inactive in cytotoxicity assays, were the most promising in the antimicrobial assays. This 
finding demonstrates the importance of testing isolated natural compounds in a variety of assays. 
 
Table 7. Antimicrobial activities of compounds 1–15. 
Compound[a] Antimicrobial activity MIC [μg mL–1]  
M. luteus S. aureus 
1 38 75 
2 36 n.a.[b] 
3 5 39 
4 46 93 
5 15 59 
10 43 43 
vancomycin[c] – 0.25 
[a] See Table S5 in the Supporting Information for compounds 6–9, 11, and 12–15. 
[b] n.a.: not active, with MIC > 145 μg mL–1. 
[c] Positive control. 
 
Conclusions 
 
A total of 16 polyketides 1–16, of which six were new, were isolated from a fungal culture of S. 
terrestris (MSX45109). Cytotoxicity assays suggested compounds 1, 4, and 12 as the most 
potent. When evaluated for antimicrobial activity, compounds 3 and 5 showed promising M. 
luteus activity. This fungus was a prolific producer of polyketides, affording the opportunity to 
examine many analogues in a series of bioassays concomitantly. Moreover, because a few of the 
known compounds were first described decades ago, this study also served to update the 
literature with spectroscopic and spectrometric data obtained with modern instruments. 
 
Experimental Section 
 
General Procedures: UV and ECD spectra were obtained with a Varian Cary 100 Bio UV/Vis 
spectrophotometer (Varian Inc., Walnut Creek, CA, USA) and an Olis DSM 17 ECD 
spectrophotometer (Olis, Inc. Bogart, GA, USA), respectively. NMR spectroscopic data were 
collected variously with a JEOL ECA‐500 NMR spectrometer, operating at 500 MHz for 1H and 
125 MHz for 13C, a JEOL ECS‐400 NMR spectrometer, operating at 400 MHz for 1H and 100 
MHz for 13C and equipped with a high‐sensitivity JEOL Royal probe and a 24‐slot autosampler 
(both from JEOL Ltd., Tokyo, Japan), or an Agilent 700 MHz NMR spectrometer (Agilent 
Technologies, Inc., Santa Clara, CA, USA), equipped with a cryoprope, operating at 700 MHz 
for 1H and 175 MHz for 13C. Residual solvent signals were utilized for referencing. High‐
resolution mass spectra (HRMS) were obtained with a Thermo LTQ Orbitrap XL mass 
spectrometer equipped with an electrospray ionization source (Thermo Fisher Scientific, San 
Jose, CA, USA). A Waters Acquity UPLC system (Waters Corp., Milford, MA, USA) utilizing a 
Waters BEH C18 column (1.7 μm; 50 × 2.1 mm) was used to check the purities of the isolated 
compounds, with data collected and analyzed with the aid of Empower software. Phenomenex 
Gemini‐NX C18 analytical (5 μm, 250 × 4.6 mm), preparative (5 μm, 250 × 21.2 mm), and 
semipreparative (5 μm, 250 × 10.0 mm) columns (all from Phenomenex, Torrance, CA, USA) 
were used with a Varian Prostar HPLC system equipped with ProStar 210 pumps and a Prostar 
335 photodiode array detector (PDA), with data collected and analyzed with the aid of Galaxie 
Chromatography Workstation software (version 1.9.3.2, Varian Inc.). Flash chromatography was 
performed with a Teledyne ISCO CombiFlash Rf 200 and Silica Gold columns (both from 
Teledyne Isco, Lincoln, NE, USA) and monitored by UV and evaporative light‐scattering 
detectors. 
 
Fungal Strain Isolation and Identification: Mycosynthetix fungal strain MSX45109 was 
isolated from leaf litter collected in a mangrove habitat in 1989. Molecular techniques were used 
to identify MSX45109 by sequencing the internal transcribed spacer (ITS) regions 1 & 2 and 
5.8S nrDNA.34 DNA extraction, PCR amplification, sequencing, and phylogenetic analyses were 
performed as described previously.1b,35 BLAST search in GenBank and the curated BOLD 
systems (http://www.boldsystems.org/index.php/IDS_OpenIdEngine) database, as well as Q‐
bank through the use of ITS rDNA sequences suggested that MSX45109 shared high sequence 
similarity with several CBS (Centraalbureau voor Schimmelcultures) strains of Setophoma 
terrestris (Pleosporales, Ascomycota) with ≥80 % query coverage and 99–100 % sequence 
identity. The top BLAST matches were downloaded with Seaview v4.4.2., and Maximum 
Likelihood analysis was performed by methods outlined earlier.36 From the results of the BLAST 
search and Maximum Likelihood phylogeny of the ITS region (Figure S28 in the Supporting 
Information), the strain MSX45109 was identified as Setophoma terrestris (H. N. Hansen) 
Gorenz J. C. Currently, three species of Setophoma have been described, with S. terrestris as the 
type species.37 The ITS sequences of four isolates of MSX45109 were deposited in the GenBank 
(accession numbers KM203887, KM203888, KM203889, and KM203890). 
 
Fermentation, Extraction, and Isolation: Storage, fermentation, and extraction procedures for 
fungal strain MSX45109 were as described previously.1b,1d,1h In brief, a seed culture of strain 
MSX45109 grown in YESD medium was used to inoculate a Fernbach flask (2.8 L, Corning, 
Inc., Corning, NY, USA) containing rice (150 g) and H2O (300 mL). The solid culture was 
incubated at room temp. for 14 days and then extracted by addition of a MeOH/CHCl3 mixture 
(1:1, 500 mL). The culture was chopped into small pieces and left to shake at 125 rpm at room 
temp., followed by vacuum filtration. The solid phase was washed with MeOH/CHCl3 (1:1, 100 
mL). CHCl3 (900 mL) and H2O (1500 mL) were added to the filtrate so that the final 
CHCl3/MeOH/H2O ratio was 4:1:5. The mixture was stirred for 0.5 h and then transferred into a 
separatory funnel. The organic bottom layer was drawn off, and the solvents were evaporated to 
dryness and then reconstituted in MeOH/CH3CN (1:1, 100 mL) and hexanes (100 mL). The 
biphasic solution was stirred for 15 min and then transferred to a separatory funnel. The 
MeOH/CH3CN layer was drawn off and the solvents were evaporated to dryness under vacuum. 
The defatted material (1.5 g) was dissolved in a mixture of CHCl3/MeOH, adsorbed onto Celite 
545, and fractionated by flash chromatography with use of a gradient solvent system of 
hexane/CHCl3/MeOH at a 40 mL min–1 flow rate and 53.3 column volumes over 63.9 min to 
afford five fractions. Fraction 3 (627 mg) was subjected to preparative reversed‐phase HPLC 
over a Phenomenex Gemini‐NX C18 preparative column with use of a gradient system of 40:60 
to 60:40 CH3CN/H2O (acidified with 0.1 % formic acid) over 30 min at a flow rate of 21.24 
mL min–1 to yield thirteen subfractions. Subfractions 4, 5, 10, and 12 yielded compounds 11 (4.2 
mg), 12 (19.6 mg), 1(35.1), and 2 (48.4 mg), which eluted at 7.8, 8.7, 25.1, and 29.0 min, 
respectively. 
 
The other subfractions were subjected to further purifications as follows: 
 
Subfraction 1 (2.3 mg) was subjected to semipreparative HPLC purification over a Phenomenex 
Gemini‐NX C18 column with use of a gradient system of 50:50 to 70:30 MeOH/H2O (0.1 % 
formic acid) over 15 min at a flow rate of 4.72 mL min–1 to yield compound 16 (0.8 mg), which 
eluted at 13.1 min. 
 
Subfraction 6 (8.5 mg) was subjected to preparative HPLC purification (Phenomenex Gemini‐
NX C18) with a gradient system of 50:50 to 70:30 MeOH/H2O (0.1 % formic acid) over 15 min at 
a flow rate of 21.24 mL min–1 to yield compounds 15 (1.7 mg) and 13 (3.7 mg), which eluted at 
8.0 and 18.9 min, respectively. 
 
Subfraction 7 (1.5 mg) was subjected to semipreparative HPLC purification over a Phenomenex 
Gemini‐NX C18 column with use of a gradient system of 50:50 to 70:30 MeOH/H2O (0.1 % 
formic acid) over 15 min at a flow rate of 4.72 mL min–1 to yield compound 6 (0.8 mg), which 
eluted at 17.5 min. 
 
Subfraction 9 (18.2 mg) was subjected to preparative HPLC purification (Phenomenex Gemini‐
NX C18) with a gradient system of 50:50 to 70:30 MeOH/H2O (0.1 % formic acid) over 15 min at 
a flow rate of 21.24 mL min–1 to yield compounds 7 (5.4 mg), 8 (1.0 mg), and 14 (2.7 mg), 
which eluted at 11.6, 13.5, and 19.5 min, respectively. 
 
An aliquot of subfraction 10 (20 mg) was further purified by preparative HPLC (Phenomenex 
Gemini‐NX C18) with use of a gradient solvent system of 70:30 to 90:10 MeOH/H2O (0.1 % 
formic acid) over 15 min at a flow rate of 21.24 mL min–1 to yield compounds 10 (0.6 mg) 
and 1 (3.1 mg), which eluted at 9.5 and 14.8 min, respectively. 
 
An aliquot of subfraction 11 (20 mg) was subjected to semi‐preparative HPLC purification over 
a Phenomenex Gemini‐NX C18 column with use of a gradient system of 70:30 to 90:10 
MeOH/H2O (0.1 % formic acid) over 15 min at a flow rate of 4.72 mL min–1 to yield compound 
3 (9.5 mg), which eluted at 12.3 min, and compound 9 (1.1 mg), which was obtained by yet 
another round of similar purification. 
 
Subfraction 13 (21.5 mg) was subjected to preparative HPLC purification (Phenomenex Gemini‐
NX C18) with a gradient system of 70:30 to 90:10 MeOH/H2O (0.1 % formic acid) over 15 min at 
a flow rate of 21.24 mL min–1 to yield compounds 2 (2.9 mg) and 4 (5.4 mg), which eluted at 
10.5 and 19.9 min, respectively, and compound 5 (2.1 mg), which was obtained by another round 
of HPLC purification. 
 
Penicillixanthone B (5): Yellow powder. [α]D20 = –112 (c = 0.03 in acetone). CD (c = 6.26 × 10–
5 M, CHCl3): λ (Δϵ) = 225 (–55.3) nm, 243 (+48.4) nm, 332 (–18.9) nm, 347 (+2.6) nm, 376 (–
8.8) nm. 1H NMR (CDCl3, 500 MHz) and 13C NMR (CDCl3, 125 MHz): see Table 1 and Figure 
S9 in the Supporting Information. UV (MeOH): λmax [log (ϵ/M–1 cm–1)] = 349 (3.64), 336 (3.63), 
250 (3.58) nm. HRMS (ESI) calcd. for C32H31O14 639.1708 [M + H]+; found 639.1691. 
 
Blennolide H (6): Yellow gum. [α]D20 = –25.3 (c = 0.01 in chloroform). CD (c = 4.27 × 10–4 M, 
MeOH): λ (Δϵ) = 231 (+11.9) nm, 269 (–20.9) nm, 298 (–19.8) nm. 1H NMR (CDCl3, 500 MHz) 
and 13C NMR (CDCl3, 175 MHz): see Table 2 and Figure S11 in the Supporting Information. 
UV (MeOH): λmax [log (ϵ/M–1 cm–1)] = 283 (3.48), 193 (3.68) nm. HRMS (ESI) calcd. for 
C16H17O6305.1020 [M + H]+; found 305.1012. 
 
11‐Deoxyblennolide D (7): Colorless oil. [α]D20 = –26.14 (c = 0.03 in chloroform). CD (c = 
1.56 × 10–4 M, CHCl3): λ (Δϵ) = 235 (+6.2) nm, 267 (–53.8) nm, 307 (–16.4) nm; 346 (+0.5) 
nm. 1H NMR (CDCl3, 500 MHz) and 13C NMR (CDCl3, 125 MHz): see Table 3 and Figure S13 
in the Supporting Information. UV (MeOH): λmax [log (ϵ/M–1 cm–1)] = 349 (3.21), 270 (3.45), 224 
(3.37) nm. HRMS (ESI) calcd. for C16H17O7 321.0969 [M + H]+; found 321.0963. 
 
Paecilin B (8): Colorless oil. [α]D20 = +42.05 (c = 0.09 in chloroform). CD (c = 5.62 × 10–4 M, 
CHCl3): λ (Δϵ) = 235 (–44.7) nm, 267 (+35.2) nm, 307 (+17.0) nm; 346 (–8.7) nm. 1H NMR 
(CDCl3, 500 MHz) and 13C NMR (CDCl3, 125 MHz): see Table 3 and Figure S14 in the 
Supporting Information. UV (MeOH): λmax [log (ϵ/M–1 cm–1)] = 346 (3.20), 271 (3.49), 193 
(3.70) nm. HRMS (ESI) calcd. for C16H17O7 321.0969 [M + H]+; found 321.0961. 
 
Blennolide I (9): Yellow powder. [α]D20 = –102.30 (c = 0.09 in chloroform). CD (c = 6.26 × 10–
5M, CHCl3): λ (Δϵ) = 241 (+13.9), 275 (–6.3) nm, 334 (–8.7) nm. 1H NMR (CDCl3, 700 MHz) 
and 13C NMR (CDCl3, 175 MHz): see Table 4 and Figure S17 in the Supporting Information. 
UV (MeOH): λmax [log (ϵ/M–1 cm–1)] = 349 (2.81), 258 (3.69), 224 (3.69) nm. HRMS (ESI) 
calcd. for C32H31O14 639.1708 [M + H]+; found 639.1682. 
 
Blennolide J (10): Yellow powder. [α]D20 = –93.5 (c = 0.08 in chloroform). CD (c = 1.72 × 10–
4M, CHCl3): λ (Δϵ) = 245 (+38.9), 262 (–14.9) nm, 337 (–13.9) nm, 377 (–16.7) nm. 1H NMR 
(CDCl3, 700 MHz) and 13C NMR (CDCl3, 175 MHz): see Table 4 and Figure S20 in the 
Supporting Information. UV (MeOH): λmax [log (ϵ/M–1 cm–1)] = 349 (3.37), 336 (3.37), 237 (3.4) 
nm. HRMS (ESI) calcd. for C32H31O14 639.1708 [M + H]+; found 639.1683. 
 
Pyrenomycin (16): Colorless oil. [α]D20 = –5.7 (c = 0.05 in chloroform). 1H NMR (CD3OD, 700 
MHz) and 13C NMR (CD3OD, 175 MHz): see Table 5 and Figure S27 in the Supporting 
Information. UV (MeOH): λmax [log (ϵ/M–1 cm–1)] = 301 (3.09), 270 (3.12), 233 (3.07) nm. 
HRMS (ESI) calcd. for C12H16O5 239.0914 [M + H]+; found 239.0909. 
 
Preparation of the (R)‐ And (S)‐MTPA Ester Derivatives of Pyrenomycin (16): [D5]Pyridine 
(400 μL) was added to compound 16 (0.1 mg), and the solution was transferred into an NMR 
tube. To initiate the reaction, S‐(+)‐α‐methoxy‐α‐(trifluoromethyl)phenylacetyl (MTPA) chloride 
(20 μL) was added with careful shaking and then monitored immediately by 1H NMR at the 
following time points: 0, 5, 10, 15, 30, 60, and 120 min. The reaction was found to be complete 
after 2 h, yielding the mono (R)‐MTPA ester derivative 16b of 16. 1H NMR spectroscopic data 
for 16b (500 MHz, [D5]pyridine): δH = 1.85 (d, J = 7.5 Hz, 3 H, H3‐13), 1.81 (m, 1 H, 12a‐H), 
1.90 (m, 1 H, 12b‐H), 4.81 (m, 1 H, 11‐H), 5.61 (m, 1 H, 3‐H) ppm. In an analogous manner, 
compound 16 (0.1 mg), dissolved in [D5]pyridine (400 μL), was treated in a second NMR tube 
with (R)‐(–)‐α‐MTPA chloride (20 μL) for 1 h to afford the mono (S)‐MTPA ester 16a. 1H NMR 
spectroscopic data for 16a (500 MHz, [D5]pyridine): δH = 1.75 (d, J = 6.9 Hz, 3 H, H3‐13), 1.70 
(m, 1 H, 12a‐H), 1.80 (m, 1 H, 12b‐H), 4.85 (m, 1 H, 11‐H), 5.65 (m, 1 H, 3‐H) ppm. 
 
Molecular Modeling Calculations: Theoretical calculations of ECD spectra for 
compounds 4, 5, and 7–10, and their corresponding enantiomers or epimers, were performed 
with the Gaussian 09 (Gaussian Inc., Wallingford CT, USA) program package as described 
previously13e (for details see the Supporting Information).38 
 
Cytotoxicity Assay: The cytotoxicities of compounds 1–15 were tested against the MDA‐MB‐
43539 human melanoma (HTB‐129, ATCC) and the SW‐62040 human colorectal adenocarcinoma 
(CCL‐227, ATCC) cell lines as described previously.41 
 
Antimicrobial Assay: Minimal inhibitory concentrations (MICs) of compounds 1–15 were 
measured against a panel of bacteria and fungi as described previously.41a All measurements 
were made in duplicate. 
 
Supporting Information: Molecular modeling calculations, UPLC chromatograms of 
compounds 1–16, 1H and 13C NMR spectra for compounds 1–16, key COSY, HMBC, and 
NOESY correlations of 4, comparison of the experimentally measured ECD spectra of 
penicillixanthone A (4) and penicillixanthone B (5), experimentally measured and calculated 
ECD spectra for blennolide H (6), comparison of the experimentally measured ECD spectra of 
blennolide I (9) and blennolide J (10), DFT B3LYP/DGDZVP global minimum energy models, 
relative Gibbs free energies (ΔGrel) and equilibrium population (p) values for the most relevant 
conformations of compounds 4, 5, and 7–10, and their corresponding enantiomers 4a, 5a, 
and 7a–10a, phylogram of the most likely tree; ECD and optical rotation data, experimentally 
measured versus literature, for compounds 1–4, 6, 8–9, and blennolide G, 1H NMR spectroscopic 
data for 1–3, NMR spectroscopic data for 4, and NMR spectroscopic data for 8 and paecilin B. 
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